These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6657514)

  • 21. Effects of vasopressin and desmopressin on memory. A double-blind study in 40 healthy volunteers.
    Guard O; Marchal G; Graule A; Dumas R; D'Athis P
    Neuropsychobiology; 1986; 15(2):80-3. PubMed ID: 3762902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of pain perception in man by a vasopressin analogue.
    Pohl J; Arnold H; Schulz A; Pause BM; Schulte HM; Fehm-Wolfsdorf G
    Peptides; 1996; 17(4):641-7. PubMed ID: 8804075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vasopressin treatment on learning in Down's syndrome.
    Eisenberg J; Hamburger-Bar R; Belmaker RH
    J Neural Transm; 1984; 60(2):143-7. PubMed ID: 6238133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No improvement in ethanol-induced memory deficits after administration of a vasopressin analog.
    Eisenhofer G; Lambie DG; Robinson BJ
    Life Sci; 1985 Dec; 37(26):2499-505. PubMed ID: 4079660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasopressin and its deamino-D-arginine analogue on renin release in the isolated perfused rat kidney.
    Konrads A; Hofbauer KG; Werner U; Gross F
    Pflugers Arch; 1978 Oct; 377(1):81-5. PubMed ID: 569283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of infusions of arginine vasopressin or 1-deamino-8-D-arginine vasopressin on common carotid vascular resistance in conscious, Long Evans rats.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1989 May; 97(1):153-7. PubMed ID: 2720303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal and clinical studies of vasopressin effects on learning and memory.
    Hamburger-Bar R; Eisenberg J; Belmaker RH
    Isr J Med Sci; 1987; 23(1-2):12-8. PubMed ID: 2952619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin.
    Richardson DW; Robinson AG
    Ann Intern Med; 1985 Aug; 103(2):228-39. PubMed ID: 3893256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator response after DDAVP: a clinico-pharmacological study.
    Mannucci PM; Rota L
    Thromb Res; 1980 Oct; 20(1):69-76. PubMed ID: 7193918
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression.
    Tyagi MG; Thomas M
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):619-24. PubMed ID: 10669908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of desmopressin-enhanced cognitive function in a neurosurgical patient.
    Dons RF; House JF; Hood D; Krehbiel M
    Mil Med; 1989 Feb; 154(2):83-5. PubMed ID: 2494586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acute and chronic treatment with desglycinamide-[Arg8]vasopressin in young male and female volunteers.
    Bruins J; Hijman R; Van Ree JM
    Peptides; 1995; 16(2):179-86. PubMed ID: 7784246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP.
    Imai Y; Nolan PL; Johnston CI
    Circ Res; 1983 Aug; 53(2):140-9. PubMed ID: 6883642
    [No Abstract]   [Full Text] [Related]  

  • 40. DDAVP, a synthetic analogue of vasopressin, in prevention of headache after lumbar puncture and lumbar pneumoencephalography.
    Hansen PE; Hansen JH
    Acta Neurol Scand; 1979 Sep; 60(3):183-8. PubMed ID: 517118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.